Publications
Publications

Publications

et chapitres de livres 2012-2020 :

2019

Descamps A, Launay O, Bonnet C, Blondel B.

Seasonal influenza vaccine uptake and vaccine refusal among pregnant women in France: results from a national Survey.

Launay O.

Risks of non-vaccination. Med Mal Infect.

Valour F, Conrad A, Ader F, Launay O.

Vaccination in adult liver transplantation candidates and récipients.

Tubiana S, Launay O, Galtier F, Tattevin P, Postil D, Vanhems P, Lanzi N, Verger P, Duval X.

Attitudes, knowledge, and willingness to be vaccinated against seasonal influenza among patients hospitalized with Influenza-Like-Illness: impact of diagnostic testing.

Detoc M, Launay O, Dualé C, Mutter C, Le Huec JC, Lenzi N, Lucht F, Gagneux-Brunon A, Botelho-Nevers E.

Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites.

Alessandrini V, Anselem O, Girault A, Mandelbrot L, Luton D, Launay O, Goffinet F.

Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women?

Loubet P, Enouf V, Launay O.

The risk of a swine influenza pandemic: still a concern?

Artaud C, Kara L, Launay O.

Vaccine Development: From Preclinical Studies to Phase 1/2 Clinical Trials.

Loubet P, Nguyen C, Burnet E, Launay O.

Influenza vaccination of pregnant women in Paris, France: Knowledge, attitudes and practices among midwives.

Launay O, Ndiaye AGW, Conti V, Loulergue P, Sciré AS, Landre AM, Ferruzzi P, Nedjaai N, Schütte LD, Auerbach J, Marchetti E, Saul A, Martin LB, Podda A.

Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial.

Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, De Angelis S, Takacs J, Ali KA, Pastore Celentano L, Larson H.

HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe.

Dutilleul A, Morel J, Schilte C, Launay O.

Les participants à la table ronde « Sujet d’actualité (1) » des Ateliers de Giens XXXIV. Comment améliorer l’acceptabilité vaccinale (évaluation, pharmacovigilance, communication, santé publique, obligation vaccinale, peurs et croyances).

Canouï E, Launay O.

History and principles of vaccination.

Assala M, Groh M, Blanche P, Vinter C, Cohen P, Le Guern V, Puéchal X, Mouthon L, Le Jeunne C, Launay O, Kernéis S.

Reply to the comment of Fayet et al. Obstacles and motivations to influenza and pneumococcal vaccination in patients with rheumatoid arthritis. A qualitative study.

2018

Durier C, Desaint C, Launay O.

Social and Behavioral Consequences of Participation in HIV Preventive Vaccine  Trials in the ANRS COHVAC Cohort.

Bahuaud M, Beaudouin-Bazire C, Husson M, Molto A, Launay O,  Batteux F, Dougados M.

Immunogenicity And Persistence Of A Prime-Boost  Re-Vaccination Strategy For Pneumococcal Vaccines In Patients With Rheumatoid  Arthritis.

N'Diaye  DS, Launay O, Picone O, Tsatsaris V, Azria E, Rozenberg F, Schwarzinger  M, Yazdanpanah Y.

Cost-effectiveness of vaccination against cytomegalovirus  (CMV) in adolescent girls to prevent infections in pregnant women living in  France.

Loubet  P, Verger P, Abitbol V, Peyrin-Biroulet L, Launay O.

Pneumococcal and  influenza vaccine uptake in adults with inflammatory bowel disease in France:  Results from a web-based study.

Piroth  L, Launay O, Miailhes P, Carrat F, Rey D.

Patients With Isolated Hepatitis  B Core Antibody:Has the Time Come to Vaccinate?

2017

Bahuaud M, Bodilis H, Malphettes M, Maugard Landre A, Matondo C, Bouscary D, Batteux F, Launay O, Fermand JP.

Immunogenicity and persistence of the 13-valent Pneumococcal Conjugate Vaccine(PCV13) in patients with untreated Smoldering Multiple Myeloma (SMM): A pilotstudy.

Kernéis S, Jacquet C, Bannay A, May  T, Launay O, Verger P, Pulcini C;  EDUVAC Study Group.

Vaccine Education of Medical Students: A Nationwide Cross-sectional Survey.

Assala M, Groh M, Blanche P, Vinter C, Cohen P, Le Guern V, Puéchal X,  Mouthon L, Le Jeunne C, Launay O, Kernéis S.

Pneumococcal and influenza vaccination rates in  patients treated with corticosteroids and/or immunosuppressive therapies  for systemic autoimmune diseases: A cross-sectional study.

Piroth L, Launay O, Miailhes  P, Carrat F, Rey D.

Isolated anti-HBc serological profile: has the time come to  vaccinate?

Kernéis S, Leprince C, Archambeau D, Eyrolle L, Leclerc P, Poupet H,  Loubinoux J, Gauzit R, Salmon D, Launay  O, Poyart C, Anract P, Morand PC.

Impact of Sequential Culture Results on  Diagnosis and De-Escalation of the Antibiotic Regimen in Joint and Bone  Infections.

Lê MP, Belarbi L, Chaix ML, Dulioust E, Mahjoub N, Salmon D, Viard JP,  Duvivier C, Peytavin G, Launay O,  Ghosn J.

Penetration and antiviral efficacy of total and unbound maraviroc,  raltegravir and rilpivirine in both female and male genital fluids from  HIV-positive patients receiving regimens containing these antiretrovirals.

Sirima SB, Durier C, Kara L, Houard S, Gansane A, Loulergue P, Bahuaud  M, Benhamouda N, Nebié I, Faber B, Remarque E, Launay O; AMA1-DiCo Study Group.

Safety and immunogenicity of a  recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with  GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b,  randomized, double-blind multi-centre trial.

Canouï E, Blanc K, Loubinoux J, Valade S, Hamard C, Lefebvre A, Amorim  S, Bébéar C, Rodriguez-Nava V, Lebeaux D, Launay  O, Alifano M, Rabbat A, Kernéis S.

The value of molecular techniques to  diagnose Ureaplasma urealyticum and Nocardia farcinica Pleuropneumonia in a  Patient with Diffuse Large B-Cell Lymphoma.

Launay O, Lewis DJM, Anemona A, Loulergue P, Leahy J, Sciré AS, Maugard A,  Marchetti E, Zancan S, Huo Z, Rondini S, Marhaba R, Finco O, Martin LB,  Auerbach J, Cohen D, Saul A, Gerke C, Podda A.

Safety Profile and Immunologic  Responses of a Novel Vaccine Against Shigella sonnei Administered  Intramuscularly, Intradermally and Intranasally: Results From Two Parallel  Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.

Casanova L, Cortaredona S, Gaudart J, Launay O, Vanhems P, Villani P, Verger P.

Effectiveness of seasonal  influenza vaccination in patients with diabetes: protocol for a nested  case-control study.

Grabar S, Groh M, Bahuaud M, Le Guern V, Costedoat-Chalumeau N, Mathian  A, Hanslik T, Guillevin L, Batteux F, Launay  O; VACCILUP study group.

Pneumococcal vaccination in patients with systemic  lupus erythematosus: A multicenter placebo-controlled randomized double-blind  study.

Loubet P, Launay O.

Maternal  influenza immunisation to reduce influenza infections and low birthweight in  infants in resource-limited countries.

2016

Vieillard V, Gharakhanian S, Lucar O, Katlama C, Launay O, Autran B, Tsong Fang RH, Crouzet J, Murphy RL, Debré P.

Perspectives for immunotherapy: which applications might achieve an HIV functional cure?

Loubet P, Guerrisi C, Turbelin C, Blondel B, Launay O, Bardou M, Blanchon T, Bonmarin I, Goffinet F, Ancel PY, Colizza V, Hanslik T, Kernéis S.

First nationwide web-based surveillance system for influenza-like illness in pregnant women: participation and representativeness of the French G-GrippeNet cohort.

Loubet P, Guerrisi C, Turbelin C, Blondel B, Launay O, Bardou M, Goffinet F, Colizza V, Hanslik T, Kernéis S; GGNET study group.

Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet.

Launay O, Rosenberg AR, Rey D, Pouget N, Michel ML, Reynes J, Neau D, Raffi F, Piroth L, Carrat F.

ANRS HB03 VIHVAC-Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.

Rondy M, Castilla J, Launay O, Costanzo S, Ezpeleta C, Galtier F, de Gaetano Donati K, Moren A.

Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.

Loulergue P, Kernéis S, Stern JB, Kassis-Chikani N, Derradji O, Escaut L, Launay O, Vittecoq D, Wyplosz B.

Intention to vaccinate against influenza among health care workers caring for immunocompromised patients.

Loubet P, Loulergue P, Galtier F, Launay O.

Seasonal influenza vaccination of high-risk adults.

Launay O, Tsatsaris V.

Maternal influenza immunisation in resource-limited settings.

2015

Rondy M, Launay O, Puig-Barberà J, Gefenaite G, Castilla J, de Gaetano Donati K, Galtier F, Hak E, Guevara M, Costanzo S; European hospital IVE network, Moren A.

2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals Euro Surveill.

Hmamouchi I, Winthrop K, Launay O, Dougados M.

Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort.

Lemoine S, Jaron B, Tabka S, Ettreiki C, Deriaud E, Zhivaki D, Le Ray C, Launay O, Majlessi L, Tissieres P, Leclerc C, Lo-Man R.

Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells.

Loubet P, Kerneis S, Groh M, Loulergue P, Blanche P, Verger P, Launay O.

Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.

Mullaert J, Abgrall S, Lele N, Batteux F, Slama LB, Meritet JF, Lebon P, Bouchaud O, Grabar S, Launay O; ANRS VIHVO Study Group.

Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.

Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F; ANRS HB04 B-BOOST study group.

Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.

2014

Launay O, Le Strat Y, Tosini W, Kara L, Quelet S, Lévy S, Danan J, Réveillon J, Houdayer J, Bouvet E, Lévy-Bruhl D; The ANRS-FORMVAC Study Group.

Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: a pre-post cluster randomized study.

Launay O, Boelle PY, Krivine A, Grenet D, Boussaud V, Rémus N, Corvol H, Chedevergne F, Hubert D, Sermet-Gaudelus I; Inserm MUCOFLU group.

Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis.

Puig-Barberà J, Natividad-Sancho A, Launay O, Burtseva E, Ciblak MA, Tormos A, Buigues-Vila A, Martínez-Úbeda S, Sominina A; the GIHSN Group.

2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network.

Zhang X, Mozeleski B, Lemoine S, Dériaud E, Lim A, Zhivaki D, Azria E, Le Ray C, Roguet G, Launay O, Vanet A, Leclerc C, Lo-Man R.

CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus.

Launay O, Le Strat Y, Tosini W, Kara L, Quelet S, Lévy S, Danan J, Réveillon J, Houdayer J, Bouvet E, Lévy-Bruhl D; The ANRS-FORMVAC Study Group.

Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: A pre-post cluster randomized study.

Kerneis S, Launay O, Turbelin C, Batteux F, Hanslik T, Boelle PY.

Long term Immune Responses to Vaccination in HIV-Infected Patients: A Systematic Review and Meta-Analysis.

Zhang X, Casartelli N, Lemoine S, Mozeleski B, Azria E, Le Ray C, Schwartz O, Launay O, Leclerc C, Lo-Man R.

Plasmacytoid Dendritic Cells Engagement by Influenza Vaccine as a Surrogate Stategy for Driving T-Helper Type 1 Responses in Human Neonatal Settings.

Loulergue P, Launay O.

Vaccinations among medical and nursing students: Coverage and opportunities.

N'Diaye DS, Yazdanpanah Y, Krivine A, Andrieu T, Rozenberg F, Picone O, Tsatsaris V, Goffinet F, Launay O.

Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France.

Loison E, Poirier-Beaudouin B, Seffer V, Paoletti A, Abitbol V, Tartour E, Launay O, Gougeon ML.

Suppression by thimerosal of ex-vivo CD4+T cell response to influenza vaccine and induction of apoptosis in primary memory T cells.

2013

Launay O, Duval X, Fitoussi S, Jilg W, Kerdpanich A, Montellano M, Schwaz Tino F, Watanveerade V, Wenzel Jürgen J, Zalcman G, Bambure V, Li P, Caplanusi A, Madan A, Gillard P and Vaughn David W.

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1vaccines: results from towo randomised trials.

Pilorgé L, Chartier M, Méritet JF, Cervantes M, Tsatsaris V, Launay O, Rozenberg F, Krivine A.

Rhinoviruses as an Underestimated Cause of Influenza-Like Illness in Pregnancy During the 2009-2010 Influenza Pandemic.

Loulergue P, Fonteneau L, Armengaud JB, Momcilovic S, Levy-Brühl D, Launay O, Guthmann JP, for the Studyvax survey group.

Vaccine coverage of healthcare students working in hospitals of the Paris region, 2009: the STUDYVAX survey.

Kernéis S, Launay O, Ancelle T, Iordache L, Naneix-Laroche V, Naneix-Laroche V, Méchaï F, Fehr T, Leroy JP, Issartel B, Dunand J, Van Der Vliet D, Wyplosz B, Consigny PH, Hanslik T.

Safety and Immunogenicity of Yellow Fever 17D Vaccine in Adults Receiving Systemic Corticosteroid Therapy: An Observational Cohort Study.

Launay O, Surenaud M, Desaint C, Ben Hamouda N, Pialoux G, Bonnet B, Poizot Martin I, Gonzales G, Cuzin L, Bourgault Villada I, Lévy Y, Choppin J, Durier C.

Long-term CD4+ and CD8+ T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC 16).

Launay O, Paul S, Servettaz A, Roguet G, Rozenberg F, Lucht F, Lambert C, Presles E, Goulvestre C, Meritet JF, Galtier F, Dubray C, Lebon P, Weill B, Batteux F.

Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine.

Durier C, Desaint C, Lucht F, Girard PM, Levy Y, May T, Michelet C, Rami A, Roman F, Delfraissy JF, Aboulker JP, Launay O.

Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adults.

48) Zhang XM, Lepelley A, Azria E, Lebon P, Roguet G, Schwartz O, Launay O, Leclerc C, Lo-Man R.

Neonatal Plasmacytoid Dendritic Cells (pDCs) Display Subset Variation But Can Elicit Potent Anti-Viral Innate Responses.

Rondy M, Puig-Barbera J, Launay O, Duval S, Castilla J, Guevara M, Costanzo S, Donati KD, Moren A.

2011-12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals.

Launay O, Duval X, Fitoussi S, Jilg W, Kerdpanich A, Montellano M, Schwarz TF, Watanveerade V, Wenzel JJ, Zalcman G, Bambure V, Li P, Caplanusi A, Madan A, Gillard P and Vaughn D W.

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.

2012

Laurichesse H, Zimmermann U, Galtier F, Launay O, Duval X, Richard P, Sadorge C, Soubeyrand B.

Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX ®) and a tetanus monovalent vaccine in healthy adults: New considerations for the management of patients with tetanus-prone injuries.

Duval X, Caplanusi A, Laurichesse H, Deplanque D, Loulergue P, Vaman T, Launay O, Gillard P.

Flexibility of interval between vaccinations with AS03(A)-adjuvanted influenza A(H1N1) 2009 vaccine in adults aged 18-60 and sup 60 years: a randomized trial.

Launay O, Krivine A, Charlier C, Truster V, Tsatsaris V, Lepercq J, Ville Y, Avenell C, Andrieu T, Artiguebielle F, Treluyer Jm, Goffinet F.

Low Rate of Pandemic A/H1N1 2009 Influenza Infection and Lack of Severe Complication of Vaccination in Pregnant Women: A Prospective Cohort Study.

Hosmalin A, Amraoui S, DeRosa AL, Jourdain JP, Vimeux L, Goujard C, Loulergue P, Launay O, Richard Y, Dutertre CA.

M-DC8+monocyte expansion and TNFa overproduction in response to LPS during HIV-1 infection.

Rousseau B, Loulergue P, Mir O, Krivine A, Kotti S, Viel E, Simon T, de Gramont A, Goldwasser F, Launay O, Tournigand C.

Immunogenicity and safety of the influenza A H1N1v2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study.

Durier C, Desaint C, Lucht F, Girard PM, Lévy Y, May T, Michelet C, Rami A, Roman F, Delfraissy JF, Aboulker JP, Launay O; for the ANRS 151 study group and the REIVAC network.

151 study group and the REIVAC network.
Long term immunogenicity of two doses of 2009A/h1N1v vaccine with and without AS03A-adjuvant in HIV-1-infected adults: ANRS 151 Randomized HIFLUVAC Trial. 

Rivière Y, Montange T, Janvier G, Marnata C, Durrieu L, Chaix ML, Isaguliants M, Launay O, Bresson JL and Pol S.

Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection.

 Scotto M, Afonso G, Osterbye T, Larger E, Luce S, Raverdy C, Novelli G, Bruno G, Gonfroy-Leymarie C, Launay O, Lemaonnier FA, Buus S, Carel JC, Boitard C, Mallone R.

HLA-B7-Restricted Islet Epitopes Are Differentially Recognized in Type 1 Diabetic Children and Adults and Form Weak Peptide-HLA Complexes.

Phung B-C, Launay O.

Vaccination against viral hepatitis of HIV-1 infected patients.

D'Alessandro E, Hubert D, Launay O, Bassinet L, Lortholary O, Jaffre Y, Sermet-Gaudelus I.

Determinants of Refusal of A/H1N1 Pandemic Vaccination in a High Risk Population: A Qualitative Approach.